0001860010-22-000002.txt : 20220301
0001860010-22-000002.hdr.sgml : 20220301
20220301212258
ACCESSION NUMBER: 0001860010-22-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORTH ANDREW C.
CENTRAL INDEX KEY: 0001860010
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 22701020
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
wf-form4_164618775853736.xml
FORM 4
X0306
4
2022-02-28
0
0001711279
Krystal Biotech, Inc.
KRYS
0001860010
ORTH ANDREW C.
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
0
1
0
0
Chief Commercial Officer
Common Stock
100
D
Stock Option (Right to Buy)
63.55
2022-02-28
4
A
0
50000
0
A
2032-02-28
Common Stock
50000.0
50000
D
The option vests in four equal annual installments beginning on February 28, 2023.
/s/ Andrew Orth
2022-03-01